HTA49 Associations of Product-Specific and Clinical Evidence Quality Characteristics With Health Technology Assessment Outcomes: A Quantitative Assessment of Appraisals for Drugs for Rare Diseases in England and Germany
Abstract
Authors
Lea Wiedmann Orlagh Carroll Ellen Nolte John Cairns